CRISPR Therapeutics: Beyond the Hype, A Foundational Investment in Gene Editing's Future
A Promising Leap for Pediatric Imaging: Bayer's Gadoquatrane Shines in Child Studies
A New Chapter for Ophthalmology: Regeneron and Sandoz Resolve Landmark Eylea Patent Battle